The Director of Egypt Healthcare Authority, Dr. ElSobky, attended the inauguration ceremony of the new Novartis International headquarters in Egypt.
Dr. ElSobky congratulated Novartis on the opening of its new headquarters and praised its commitment to providing the latest treatments for heart disease, cancer, immune disorders, and neurological conditions, thereby contributing to improved patient care and a healthier future for Egypt.
Dr. ElSobky emphasized the promising future of the pharmaceutical sector, highlighting the increased regulatory framework, attractiveness, and suitability of the Egyptian market for further investments in both healthcare and pharmaceuticals.
Dr. ElSobky recognized Novartis as a valuable partner and expressed appreciation for the collaborative efforts of pharmaceutical companies with government institutions and agencies. These collaborations encompass training programs, health awareness initiatives, and sustainable healthcare transformation.
Dr. ElSobky concluded by emphasizing the importance of public-private sector collaboration in developing and implementing shared visions to improve access to healthcare services, enhance their quality, and achieve the goals of Egypt Vision 2030.
